(Q30439109)

English

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium (English)

1 reference

Europe PubMed Central

19 August 2017

7

object named as

Kunle Odunsi

0 references

9

object named as

Lloyd Old

1 reference

Europe PubMed Central

19 August 2017

Holden T. Maecker

6

object named as

Holden Maecker

1 reference

Europe PubMed Central

19 August 2017

author name string

Cedrik Michael Britten

1

1 reference

Europe PubMed Central

19 August 2017

Sylvia Janetzki

2

1 reference

Europe PubMed Central

19 August 2017

Leah Ben-Porat

3

1 reference

Europe PubMed Central

19 August 2017

Timothy M Clay

4

1 reference

Europe PubMed Central

19 August 2017

Michael Kalos

5

1 reference

Europe PubMed Central

19 August 2017

Michael Pride

8

1 reference

Europe PubMed Central

19 August 2017

Axel Hoos

10

1 reference

Europe PubMed Central

19 August 2017

Pedro Romero

11

1 reference

Europe PubMed Central

19 August 2017

HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group

12

1 reference

Europe PubMed Central

19 August 2017

publication date

4 March 2009

1 reference

Europe PubMed Central

19 August 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

19 August 2017

58

1 reference

Europe PubMed Central

19 August 2017

1701-1713

1 reference

Europe PubMed Central

19 August 2017

10

1 reference

Europe PubMed Central

19 August 2017

https://scigraph.springernature.com/pub.10.1007/s00262-009-0681-z

0 references

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

CD8+ T cell efficacy in vaccination and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Statistical mixture modeling for cell subtype identification in flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Twelve immunotherapy drugs that could cure cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Polyfunctional T cell responses are a hallmark of HIV-2 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

The role of flow cytometry in the interferon-gamma-based diagnosis of active tuberculosis and its coinfection with HIV-1--A technically oriented review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Toward the harmonization of immune monitoring in clinical trials: quo vadis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

A clinical development paradigm for cancer vaccines and related biologics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Immune monitoring of T-cell responses in cancer vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Human T cell responses against melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Breast cancer vaccines: a clinical reality or fairy tale?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Standardization of cytokine flow cytometry assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Part I: Vaccines for solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Monitoring immune responses in cancer patients receiving tumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

20 June 2018

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

26 November 2018

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

26 November 2018

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714899

26 November 2018

Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19259668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-009-0681-Z

1 reference

Europe PubMed Central

19 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30439109&oldid=2058817827"